+44 (0) 1793 575 050
customerservice@regenmedical.co.uk

Part of the Joint Operations family

GET IN TOUCH TO FIND OUT MORE

EpiFix®

EpiFix® is a dehydrated Human Amnion/ Chorion Membrane (dHACM) allograft and is composed of multiple layers including a single layer of epithelial cells, a basement membrane and an avascular connective tissue matrix. EpiFix® is a minimally manipulated, dehydrated, non-viable cellular amniotic membrane allograft that contains multiple extracellular matrix proteins, growth factors, cytokines and other specialty proteins present in amniotic tissue to provide a barrier membrane that enhances healing.

EpiFix® Amnion/Chorion Membrane Allograft for Acute and Chronic Wound Care

  • Enhances Healing
  • Modulates Inflammation
  • Reduces Scar Tissue Formation

EpiFix® is processed using the PURION® Process, a unique approach that provides an added level of tissue safety and ease of use. EpiFix® may be stored at ambient conditions for up to 5 years and is also available in a particulate configuration. With a variety of sizes available, EpiFix® has size-appropriate grafts to minimize wastage.

Over one million MiMedx allografts have been distributed to date with zero reported adverse reactions attributed to our products†
†As of February 1, 2018.


For more information on RCT and to take a look at the clinical evidence review click here

Sizing & Product Codes

EpiFix is offered in various sizes – Please call 01793 575050 or complete the contact form and we will get in touch.

Recovery & Quality Control

All tissue recovered meets stringent specifications during donor screening and laboratory testing to reduce the risk of transmitting infectious disease. EpiFix allografts are procured and processed in the United States according to standards and/or regulations established by the American Association of Tissue Banks (AATB) and the United States Food & Drug Administration (FDA). All tissues are recovered under full informed consent of the donors (mothers of the newborn children). The donors have consented to the transfer of the allografts to third parties. A thorough medical and social history of the donor is also obtained. The listed communicable disease testing is performed by a laboratory registered with FDA to perform donor testing and certified to perform such testing on human specimens in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493, or that has met equivalent requirements as determined by the Centers for Medicare and Medicaid Services (CMS).

The donor is screened for:
HIV-1&2 Plus 0 Antibody
Hepatitis B Surface Antigen
HIV Type 1 (Nucleic Acid Test (NAT))
Hepatitis C Antibody
HTLV-1&2 Antibody
Hepatitis C Virus (Nucleic Acid Test (NAT))
Syphilis (Serologic Test)
Hepatitis B Virus (Nucleic Acid Test (NAT))
Hepatitis B Core Antibody
West Nile Virus (Nucleic Acid Test (NAT))*
*WNV NAT screening conducted on donors based on exposure risk per FDA Guidance for Industry.

Only tissue from donors with acceptable test results, according to the standards of MiMedx Tissue Services, LLC, as well as the standards and/or regulations of all state and federal regulatory bodies, are released.

EpiFix®

EpiFix® is a dehydrated Human Amnion/ Chorion Membrane (dHACM) allograft and is composed of multiple layers including a single layer of epithelial cells, a basement membrane and an avascular connective tissue matrix. EpiFix® is a minimally manipulated, dehydrated, non-viable cellular amniotic membrane allograft that contains multiple extracellular matrix proteins, growth factors, cytokines and other specialty proteins present in amniotic tissue to provide a barrier membrane that enhances healing.

EpiFix® Amnion/Chorion Membrane Allograft for Acute and Chronic Wound Care

  • Enhances Healing
  • Modulates Inflammation
  • Reduces Scar Tissue Formation

EpiFix® is processed using the PURION® Process, a unique approach that provides an added level of tissue safety and ease of use. EpiFix® may be stored at ambient conditions for up to 5 years and is also available in a particulate configuration. With a variety of sizes available, EpiFix® has size-appropriate grafts to minimize wastage.

Over one million MiMedx allografts have been distributed to date with zero reported adverse reactions attributed to our products†
†As of February 1, 2018.


For more information on RCT and to take a look at the clinical evidence review click here
Sizing & Product Codes

EpiFix is offered in various sizes – Please call 01793 575050 or complete the contact form and we will get in touch.

Recovery & Quality Control

All tissue recovered meets stringent specifications during donor screening and laboratory testing to reduce the risk of transmitting infectious disease. EpiFix allografts are procured and processed in the United States according to standards and/or regulations established by the American Association of Tissue Banks (AATB) and the United States Food & Drug Administration (FDA). All tissues are recovered under full informed consent of the donors (mothers of the newborn children). The donors have consented to the transfer of the allografts to third parties. A thorough medical and social history of the donor is also obtained. The listed communicable disease testing is performed by a laboratory registered with FDA to perform donor testing and certified to perform such testing on human specimens in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493, or that has met equivalent requirements as determined by the Centers for Medicare and Medicaid Services (CMS).

The donor is screened for:
HIV-1&2 Plus 0 Antibody
Hepatitis B Surface Antigen
HIV Type 1 (Nucleic Acid Test (NAT))
Hepatitis C Antibody
HTLV-1&2 Antibody
Hepatitis C Virus (Nucleic Acid Test (NAT))
Syphilis (Serologic Test)
Hepatitis B Virus (Nucleic Acid Test (NAT))
Hepatitis B Core Antibody
West Nile Virus (Nucleic Acid Test (NAT))*
*WNV NAT screening conducted on donors based on exposure risk per FDA Guidance for Industry.

Only tissue from donors with acceptable test results, according to the standards of MiMedx Tissue Services, LLC, as well as the standards and/or regulations of all state and federal regulatory bodies, are released.

GET IN TOUCH TO FIND OUT MORE